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Rationale: There is a growing body of evidence demonstrating the therapeutic potential of ayahuasca 
for treating depression and anxiety. However, the mechanisms of action involved in ayahuasca’s 
therapeutic effects are unclear. Mindfulness and cognitive flexibility may be two possible 
psychological mechanisms. Like other classic psychedelics, ayahuasca also leads to an 'afterglow' 
effect of improved subjective wellbeing that persists after the acute effects have subsided. This period 
may offer a window of increased therapeutic potential.  
Objective: to explore changes in mindfulness and cognitive flexibility before, and within 24 hours 
after ayahuasca use. 
Methods: Forty-eight participants (54% female) were assessed on measures of mindfulness (Five 
Facets Mindfulness Questionnaire, FFMQ), decentering (Experiences Questionnaire, EQ) and 
cognitive flexibility (Cognitive Flexibility Scale, CFS), and completed the Stroop and Wisconsin 
Picture Card Sorting Task (WPCST) before drinking ayahuasca, and again within 24-hours. 
Results: Mindfulness (FFMQ total scores and four of the five mindfulness facets; Observe, Describe, 
Act with Awareness and Non-reactivity) and decentering (EQ) significantly increased in the 24 hours 
after ayahuasca use. Cognitive flexibility (CFS and WPCST) significantly improved in the 24 hours 
after ayahuasca use. Changes in both mindfulness and cognitive flexibility were not influenced by 
prior ayahuasca use. 
Conclusions: The present study supports ayahuasca’s ability to enhance mindfulness and further 
reports changes in cognitive flexibility in the 'afterglow' period occur, suggesting both could be 
possible psychological mechanisms concerning the psychotherapeutic effects of ayahuasca. Given 
psychological gains occurred regardless of prior ayahuasca use suggests potentially therapeutic effects 
for both naïve and experienced ayahuasca drinkers. 
 













Renewed interest in the effects of classical psychedelics is providing evidence for their potential 
efficacy in treating a range of psychiatric illnesses, and specifically, in improving outcomes for 
treatment resistant patients (Bouso and Riba, 2014; Griffiths et al., 2016; Grob et al., 2011; Moreno et 
al., 2006). Given the high failure rates in current treatments the search for alternative treatment 
strategies is crucial (Vollenweider and Kometer, 2010). Ayahuasca is one such classic psychedelic 
with potential therapeutic effects; shown to be beneficial in treating depression (Griffiths et al., 2016), 
anxiety (Grob et al., 2011) and substance abuse disorders (Bouso and Riba, 2014). 
 
Ayahuasca is a dimethyltryptamine (DMT) containing psychoactive plant tea most commonly 
combining two plants with water; the vine of Banisteriopsis caapi (B. caapi) and the leaves of 
Psychotria Viridis (P.Viridis) (Domínguez-Clavé et al., 2016). The combination of these plants 
renders the DMT in P. Viridis orally active by inhibiting its degradation in the body and allowing 
uptake into the central nervous system, producing an altered state of consciousness that lasts between 
four to six hours, with peak effects between one and two hours after ingestion (Prickett and Liester, 
2002). 
 
Like other classical psychedelics, ayahuasca’s primary neural mechanism of action is as a 5HT 
agonist (Sampedro et al., 2017). Secondary effects as a 5HT2a agonist are thought to underlie the 
increased positive mood experienced in ayahuasca users for up to two months after use, commonly 
referred to as the ‘afterglow’ period (Sampedro et al.,2017). However, given the complexity and high 
co-morbidity of the mental health problems that ayahuasca has been shown to effect, there are likely 
to also be psychological mechanisms that contribute to the increased psychological wellbeing 
observed in ayahuasca users in this afterglow period and longer term (Soler et al., 2016). Mindfulness 
and cognitive flexibility have recently been suggested as two such possible mechanisms which may 
be associated with ayahuasca’s therapeutic effects (Kuypers et al., 2016; Carhart-Harris et al., 2014). 
 
Mindfulness is a multi-faceted construct which is broadly defined as “paying attention in a particular 
way: on purpose, in the present moment, and non-judgmentally.” (Kabat-Zinn, 2003). It is considered 
to have five distinct facets which can be measured using the Five Facets Mindfulness Questionnaire 
(FFMQ; Baer et al., 2006) including: 1) observing, 2) describing, 3) acting with awareness, 4) non-
judging of inner experience and 5) non-reactivity to inner experience (Baer et al., 2006). Mindfulness-
based interventions have proven clinical efficacy in treating numerous psychiatric disorders, including 
depression, anxiety and addictions (Goldberg et al., 2018).  Decentering is a closely related 
psychological construct, which is the ability to take a detached view of one’s own thoughts and 
emotions, considering them as temporary events of the mind (Fresco et al., 2007). It is considered to 
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mediate positive behavioural and psychological changes following mindfulness training (Hayes-
Skelton and Graham, 2012). Both decentering and mindfulness have been shown to increase 
following a single dose of ayahuasca. Soler et al., (2016) found levels of mindfulness (as measured by 
the FFMQ) and decentering (as measured by the Experiences Questionnaire, Fresco et al., 2007) 
significantly increased in the 24 hours after ingestion in 25 ayahuasca users (23 had prior experience 
with ayahuasca, using on average 79 times (range 1–500). They found that ayahuasca affected the 
mindfulness facets differently, with only non-judging and non-reactivity to inner experience 
significantly increasing following use. Uthaug et al., (2018) have since found three of the five 
mindfulness facets (non-judging, acting with awareness and observing) increased the day after 
ayahuasca use in a large (N=57) sample of ayahuasca users with a range of experience, which 
significantly correlated with a reduction in depression scores. Sampedro et al., (2017) replicated Soler 
et al's (2016) findings in 16 experienced ayahuasca users (previous use of an average of 62 ± 99 
times), and further assessed the neural correlates 24 hours after use and again two months later. They 
found that increased connectivity between the anterior cingulate cortex (ACC), a structure involved in 
emotional processing and cognitive control, and the posterior cingulate cortex (PCC), a key hub of the 
default mode network (DMN) involved in the sense of “self,” predicted increases in mindfulness 24 
hours after using ayahuasca, and sustained elevations in the non-judge facet of mindfulness two 
months after use. Ayahuasca may therefore lead to mid-term increases in mindfulness which suggests 
a therapeutic window of opportunity lasts beyond the acute effects of ayahuasca. Another recent study 
showed two ayahuasca sessions led to increases in the non-judging subscale of the FFMQ which are 
comparable to gains made in an 8-week Mindfulness-based Stress Reduction course (Soler et al., 
2018). Improving this capacity is therapeutically significant as it promotes a person’s ability to 
tolerate potentially distressing thoughts, emotions and life situations by taking a less judgmental and 
more impersonal stance towards them (Soler et al., 2018). Taken together these findings support the 
assertion of Dominguez-Clave et al, (2016) that the mindfulness enhancing properties of ayahuasca 
could be used therapeutically to promote emotional reprocessing in patients with depression, 
addiction and personality disorders. 
 
A second possible psychological mechanism that could account for the psychotherapeutic benefits 
seen with ayahuasca is cognitive flexibility. Broadly defined, cognitive flexibility is the ability to shift 
perspective or approach in order to adapt to change in the environment (Johnco at al., 2014) and 
involves executive function abilities of problem solving and response inhibition (Johnco et al., 2014). 
Neuro-anatomically, cognitive flexibility is associated with the ACC and medial pre-frontal cortex 
(Bissonette et al., 2013; Kim et al., 2011). More recently its definition has expanded to a broader 
concept of ‘mental flexibility’ which also involves psychological and behavioural processes (Martin 
and Rubin, 1995, p 623). Higher cognitive flexibility has been associated with increased 
psychological well-being (Hayes et al., 2006), whereas cognitive inflexibility or rigidity is associated 
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with psychopathology (Hayes et al., 2006). Low cognitive flexibility can also be a barrier to achieving 
therapeutic outcomes in treatment and therapeutic approaches which help to increase cognitive 
flexibility have shown efficacy (Johnco et al., 2014). A growing body of neuropsychological evidence 
points to the potential of cognitive flexibility as a psychological mechanism which is involved in 
ayahuasca’s therapeutic effects.  Ayahuasca has been shown to acutely affect three key brain 
networks which are implicated in cognitive flexibility; DMN (in which the mPFC and  PCC is a key 
hub), central executive network (CEN) and the Salience Network (SN) (in which the ACC is 
involved). Ayahuasca temporarily disrupts the neural hierarchies of these networks by exciting 
posterior regions while loosening the “cognitive grip” exerted by frontal regions responsible for 
executive control (Alonso et al., 2015). Palhano-Fontes et al., (2015) also found decreased functional 
connectivity in parts of the DMN acutely under the effects of ayahuasca, consistent with other 
classical psychedelics (Hermle et al., 1992; Vollenweider et al., 1997; Gouzoulis-Mayfrank et al., 
1999; Riba et al., 2006).  
 
Ayahuasca has also been associated with better neuropsychological performance in experienced users 
relative to controls and less experienced users in aspects of cognitive flexibility. Bouso et al., (2012) 
found experienced ayahuasca users (n=127) performed better than closely matched controls both at 
baseline and one year later, on two measures of cognitive flexibility; Stroop and the Wisconsin 
Picture Card Sorting Task (WPCST) suggesting repeated ayahuasca use may be associated with 
sustained improvements in cognitive flexibility. Neuroanatomically, Stroop and the WPCST are 
associated with activation in the medial prefrontal cortex (mPFC) and ACC. The mPFC is part of the 
DMN, affected acutely after ayahuasca ingestion. The ACC is an area of the brain shown to be thicker 
in experienced ayahuasca users than controls (Bouso et al., 2015). Interestingly, studies of executive 
function in people with severe depression found they performed worse than healthy controls on the 
WPCST (Leinonen, T. I. K.-M., 2000). Given evidence of long-term structural brain changes to the 
PCC and ACC in experienced ayahuasca users (Bouso et al., 2015), it is possible that ayahuasca use 
leads to structural brain changes that account for positive changes in cognitive flexibility (Bouso et 
al., 2012). As well as explaining neuropsychological differences(Bouso et al, 2013), this could also 
potentially account for the increased significance in changes to mindfulness scores found by Soler et 
al (2016) after controlling for previous ayahuasca use as a secondary analysis in their study. However, 
not all studies have shown acute or long-term differences in cognitive flexibility between experienced 
ayahuasca users and psychedelic naïve controls or inexperienced users (Barbosa et al., 2016; Doering-
Silveira et al., 2005), nor is it clear if changes in cognitive flexibility occur during both the acute and 
sub-acute phases of ayahuasca ingestion. For example, Kuypers et al., (2016) found improvements in 
more flexible divergent thinking acutely under the effects of ayahuasca, whereas Uthaug et al., (2018) 
found divergent thinking was not improved the day after ayahuasca use, but less flexible convergent 
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thinking was significantly increased 4 weeks later. Given these inconsistencies across the literature 
with regards changes to cognitive flexibility, further research is needed.  
 
In summary, previous research has found increases in mindfulness in the ‘afterglow’ period (24 
hours) following ayahuasca use, as well as an association between the acute effects of ayahuasca and 
changes in cognitive flexibility and associated neural networks. Long-term changes to cognitive 
flexibility in experienced ayahuasca users may also be linked to structural brain changes associated 
with ayahuasca exposure (Bouso et al., 2012, 2015), but whether changes in cognitive flexibility 
occur specifically in the afterglow period needs further exploration. To further explore whether 
mindfulness and cognitive flexibility are potential psychological mechanisms associated with 
ayahuasca’s therapeutic effects the current study aimed to assess changes in mindfulness, decentering 
and cognitive flexibility at both baseline (pre-ayahuasca) and within 24 hours following ayahuasca 
use (post-ayahuasca).  Previous research has distinguished  between experienced and inexperienced 
users (i.e. based on amount of prior use) yet we are still unclear on the role of prior use in relation to 
these specific psychological mechanisms, therefore dependent on the range of prior use reported it 
may be necessary to control for prior ayahuasca experience. Given the previous literature 
demonstrating an association between ayahuasca use and mindfulness gains in this 24-hour afterglow 
period, we expect to see a significant increase in participants’ total mindfulness and decentering 
scores in the 24 hours following ayahuasca use relative to baseline, and to determine whether there 






Participants were a self-selected sample, recruited through advertisements emailed to the mailing lists 
of groups with an interest in psychedelics. Participants were eligible to take part in the study if they 
were over 18, had used ayahuasca in the past or had considered using it in the future. Participants 
were excluded if they self-reported current or prior drug dependency (including alcohol), current 
psychiatric or medical diagnoses, use of prescribed psychiatric medication, were receiving any form 
of psychological treatment and had a history of brain damage, head injury or epilepsy. Participants 
were required to abstain from using any drugs or alcohol (except nicotine) for at least 24 hours prior 
to assessment. The study was granted ethical approval by the University of East London Ethics 
Committee.  
 
54 participants were initially recruited as meeting the inclusion criteria.  48 completed both 
assessment points, (with 6 failing to attend time-point 2 assessment point). Twenty-six (54%) female. 
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Mean age 38.48 (SD=7.21) years. Participants were predominantly white (67%, n=32), highly 
educated (83%, n=40; educated to degree level or above) and with English as their first language 
(75%, n=36). Previous number of times participants had used ayahuasca ranged from 0-130 times.  
Six (12.5%) were psychedelic naïve participants, 10 reported previous use between 1-5 times 
(20.8%), 14 had used 6-10 times (29.2%) and 18 had used >10 times (37.5%). Total years of use 
ranged from 0-9 years. One participant (2.1%) had last used ayahuasca two weeks before testing, and 
the remaining (97.9%) had not used ayahuasca for one month or more.  There were no ayahuasca-
dependent participants (as measured by the Severity of Dependence Scale, Gossop 1995).  
 
Setting 
Participants were members of an ayahuasca-using group who attended one of two secular ayahuasca 
ceremonies in a naturalistic setting between 2017 and 2018. Both ceremonies were conducted in a 
group format with the same proceedings. The researcher met with participants prior to the ceremony 




Following informed consent participants completed the following measures in the order presented 
below. They were completed at time point 1 (baseline) and again approximately 24 hours after using 
ayahuasca (time-point 2). Each assessment session lasted approximately 30 minutes.  
 
Personal history questionnaire: which captured basic demographic information including: 
gender, age, ethnicity, first language and highest level of education.  Drug use history 
questionnaire: designed specifically for this study, questions addressed participants self-
reported drug use (including alcohol and tobacco and other classic psychedelics) and details 
on patterns of ayahuasca use e.g. date first taken, date last taken, estimated lifetime use and 
use in the last 12 months. 
 
Severity of Dependence Scale (SDS; Gossop, 1995) 
The SDS is a brief 5-item questionnaire adapted to assess participants’ levels of psychological 
dependence on ayahuasca. Items are scored on a 4-point scale ranging from 0-3. Higher total 
scores indicate higher levels of dependence. The scale has demonstrated excellent 
psychometric properties and validity for use with a diverse range of drug users (Gossop, 
1995).  
 
Five Facets Mindfulness Questionnaire-Short Form (FFMQ; Baer et al., 2006).  
The FFMQ-Short Form is a 24 item validated self-report questionnaire which measures five 
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mindfulness facets; 1)observe: noticing internal and external experiences e.g. body 
sensations, thoughts, emotions, sounds, 2) describe: putting words to or labelling the internal 
experience, 3) act with awareness: focusing on activities in the present moment rather than 
responding habitually, 4) non-judge: taking a non-evaluative view of internal and external 
experiences in the present moment, and 5) non-react: maintaining equanimity with the flow of 
thoughts and feelings as they arise without getting caught up in or carried away by them 
(Bohlmeijer et al, 2011). Items are scored on a 5-point Likert scale; from 1 (never or very 
rarely true) to 5 (very often or always true). Example items include, “I tell myself I shouldn’t 
be feeling the way I’m feeling,” and “I pay attention to physical experiences such as the wind 
in my hair or the sun on my face.” Higher scores indicate higher levels of mindfulness, with a 
total score and five subscale scores. The FFMQ has demonstrated good internal reliability and 
adequate psychometric properties in both clinical and non-clinical samples (Baer et al., 2008). 
Cronbachs alpha = 0.85 in the current sample.  
 
Experiences Questionnaire (EQ; Fresco et. al, 2007) 
The EQ is a validated 11 item measure of decentering for example, “I can slow my thinking at 
times of stress,” and “I can observe unpleasant feelings without being drawn into them.” 
Higher total and mean scores represent higher levels of decentering. EQ items are scored on a 
5-point Likert scale ranging from never (1) to all the time (5). The EQ has demonstrated good 
construct validity and internal consistency, for use in meditating and non-meditating samples 
(Soler et al., 2014). Cronbachs alpha = 0.84 in the current sample. 
 
Cognitive Flexibility Scale (CFS; Martin and Rubin, 1995) 
The CFS is a validated measure of cognitive flexibility, measuring the ability to switch 
between thoughts and actions, based on the willingness to be flexible, a belief in self efficacy 
and awareness of alternative ways of responding to situations and experiences (Martin and 
Rubin, 1995) and has proved effective in predicting symptoms in depression, anxiety and 
substance abuse disorders as well psychological wellbeing in non-clinical samples (Lee and 
Orsillo, 2014). Consisting of 12 items each are scored on a 6-point Likert Scale ranging from 
(1) strongly disagree to (6) strongly agree. An example item is, “I have many possible ways 
of behaving in a given situation.” Higher total scores indicate higher cognitive flexibility. 
Cronbachs alpha = 0.81 in the current sample. 
 
Stroop colour and word task (Stroop; Stroop, 1935) 
A computerised version of the Stroop test was used, measuring aspects of cognitive flexibility 
including selective attention, conflict monitoring and resistance to interference. Thirty-eight 
colour-words were displayed in turn, on screen (“red”, “green”, “blue”) in congruent and 
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incongruent colours. Participants had to use a key on the keyboard that corresponded to a 
colour word (Z=red, X=blue, N=green, M=yellow) to select the written colour word whilst 
ignoring the colour it is written in. Performance was measured by number of errors and 
reaction time in the congruent and incongruent conditions. Better performance was reflected 
as lower mean reaction times and lower number of mean errors.  A parallel version with 
different trial orders was used at each time-point. 
 
Wisconsin Picture Card Sorting Task (WPCST; Berg, 1948) 
The WPCST is the most widely used test of cognitive flexibility (Heaton, 1981) consisting of 
"set-shifting," measuring cognitive flexibility by requiring participants to creatively problem 
solve to work out the picture card sorting rule and adapting to changing rules whilst inhibiting 
impulsive responding (Berg, 1948). A simplified, computerised version of the WPCST was 
used whereby participants had to match 36 test cards to stimulus cards presented on screen, 
without knowing the rule by which the test card matched the stimulus cards. Cards were 
displayed in 3 separate trial blocks, one for colour, shape and number. The sorting rule 
changed for each trial block (with no warning). In each trial, 4 stimulus cards appear at the 
top of the computer screen. These cards vary in colour, type of shape, and number of shapes 
on the cards. A test card is then displayed at the bottom of the screen. Participants were 
instructed to match the test card with one of the 4 stimulus cards by clicking on the stimulus 
card they thought it matched. Feedback is displayed on screen after a selection indicating 
whether the card had been matched correctly or not. Better performance was indicated by 
higher percentage of correct answers, indicating a participant had worked the sorting rule out 
more quickly and continued to sort cards correctly throughout the remainder of the trial bock. 
Mean reaction times of correct answers was also calculated; faster reaction times indicating 
better performance. A parallel version of this task was used at each time-point (pre- and post-




Total and mean scores were calculated for all questionnaire measures. Stroop task mean scores were 
calculated for reaction time and number of errors by congruency conditions. WPCST mean scores 
were calculated for reaction time and mean percentage of the number of correct answers. Of the 48 
participants who completed both time points, there were no incomplete datasets. Data was analysed 
using SPSS 23.  Given the wide range of prior ayahuasca use in the sample (from 0-130 times), 
repeated  measures ANCOVAs were conducted on all outcome measures; the FFMQ, EQ, CFS and 
WPSCT between the two-time points (baseline pre-ayahuasca and 24-hours post-ayahuasca), and 
prior ayahuasca use (lifetime) as the covariate. A 2x2 repeated measures ANCOVA was conducted on 
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the Stroop reaction times based on congruency (congruent and incongruent) and time (baseline and 
post ayahuasca) to establish the interference effect over time, with previous ayahuasca use (lifetime) 





Means (and SD) for all questionnaires at both time-points are shown in Table 1. Mean scores showed 
increases on all questionnaire measures of mindfulness and cognitive flexibility and all five subscales 
of the FFMQ between the two time points. Significant increases were found for the FFMQ total 
[F(1,46)=-8.21, η²=.15), CFS [F(1,46) =8.25, η²= .15] and EQ [F(1,46) = 4.15, η²= .08]. Of the five 
FFMQ subscales, significant differences were found for observe [F(1,46) =13.38, η²= .24], describe 
[F(1,46)= 3.76, η²=.08], act with awareness [F(1,46)=7.08, η²=.13], and non-react [F(1,46)=0.02, η²= 
.10]. See table 1 for further details. In all cases there were no significant covariate interaction between 
time and previous ayahuasca use (all p’s>0.05). 
 
Table 1. Mean (SD) and significant and observed power for all measures of mindfulness and 
cognitive flexibility at time-point 1 (baseline) and time-point 2 (post-ayahuasca)  
 
 Baseline Post Ayahuasca P Observed 
Power 
FFMQ (total) 3.58 (0.46) 3.75 (0.62) .003
* 
0.80 
FFMQ Subscales:      
1. Observe 3.99 (0.76) 4.23 (0.79) <.00
1** 
0.95 
2. Describe 4.76 (0.89) 5.00 (0.95) .03* 0.48 
3. Act with 
awareness 





3.23 (0.78) 3.33 (0.92) .06 0.33 
5. Non-react 3.36 (0.76) 3.55 (0.81) .015
* 
0.61 





CFS 57.38 (7.11) 59.35 (7.87) .006
* 
0.80 





4195.61(4617.67) 0.14 0.32 
% of Correct 
responses 




FFMQ=Five Facets Mindfulness Questionnaire, EQ = Experiences Questionnaire, CFS=Cognitive 





Neuropsychological Task Performance 
 
WPCST: Means (and SD) for the WPCST outcome measures at both time-points are reported in Table 
1. There was no significant effect of time on reaction times on the WPSCT [F(1, 46)=2.30, η²= .05]. 
Participants made significantly more correct responses 24 hours after ayahuasca relative to before 
[F(1, 46)=2.30, η²= .05]. In all cases there were no significant covariate interactions between time and 
previous ayahuasca use (all p’s>0.05). Stroop: Figures 1 and 2 show the mean reaction times (ms) and 
number of errors for the Stroop by congruency and over the two-time points. There was a significant 
main effect of condition on reaction time [F(1, 46) = 58.28, η²= .56] and number of errors [F(1, 46) = 
20.42, η²= .31). There was no significant main effect of time on reaction time [F(1, 46) = 1.65, η²= 
.04] or number of errors [F(1, 46) = 1.64, η²= .03]. There was a significant interaction between time 
and condition on number of errors F (1, 46) = 4.11, but not for reaction time [F(1, 46) = .02, η²= .001) 
(See figure 1). In all cases there was no significant covariate interaction between time and previous 
ayahuasca use (all p’s>0.05). 
 





The current study aimed to assess changes in mindfulness, decentering and cognitive flexibility over 
two time points; baseline (pre-ayahuasca) and within 24 hours following ayahuasca use (post-
ayahuasca), whilst controlling for prior ayahuasca use. We found mindfulness (as measured by the 
FFMQ) and decentering (measured by the EQ) significantly increased in the 24 hours after use. 
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Cognitive flexibility (as measured by the CFS and the WPCST) was also significantly improved in the 
24 hours after ayahuasca use compared to baseline. Changes in both mindfulness and cognitive 
flexibility were not influenced by prior ayahuasca use. This is in-keeping with previous research 
looking at mindfulness and cognitive flexibility in the afterglow period which have found no 
differences in changes associated with previous use (e.g. Uthaug, 2018 and Sampedro et al 2017).  
Collectively, therefore evidence suggests even naive users can potentially benefit from these 
mindfulness and cognitive flexibility gains, however this may be only in the short term (up to 4 
weeks) which contradicts evidence indicating long term changes in cognitive flexibility (Bouso et al., 
2012).  Thus, to clearly elucidate the role of prior use on such psychological mechanisms both in the 
short and long-term, more controlled studies are needed. 
 
Self-reported levels of mindfulness and decentering were found to be increased in the 24 hours after 
drinking ayahuasca, with increases seen in four of the five subscales of the FFMQ (Observing, 
Describing, Acting with Awareness and Non-reactivity to inner experience) indicating that both 
attentional and emotional acceptance facets of mindfulness were affected by ayahuasca use. These 
findings are consistent with previous studies (Uthaug et al., 2018; Soler et al., 2016; Sampedro et al., 
2017) insofar as they demonstrate overall mindfulness (assessed by total scores on the FFMQ) and 
decentering is increased in the 24 hours after drinking ayahuasca. However, differences between 
studies reside in the findings on individual subscales. Two of these previous studies found changes on 
only two of the five subscales (non-reactivity and non-judging of inner experience); both of which 
represent facets of emotional acceptance, whereas in line with Uthaug et al., (2018) we have further 
demonstrated effects of ayahuasca on two of the same attentional facets – observing and acting with 
awareness, and our study has additionally found the describing subscale to be significantly increased 
following ayahuasca use.  Together these findings suggest that both attentional and emotional 
acceptance facets are affected by ayahuasca use. Inconsistencies in the findings for the facet subscales 
could be explained by the differences in samples (e.g. sample size, range of ayahuasca use) and 
measures. For example, all previous studies (Soler et al., 2016; Sampedro et al., 2017) have used the 
full length 39-item version of the FFMQ. Equally studies looking at mindfulness gains following 
meditation training also report inconsistencies in facet level changes and suggests different amounts 
of previous meditation experience may account for these inconsistencies (Pang and Ruch, 2018). As 
neither this nor previous studies have controlled for previous meditation experience within the 
samples, this could account for such inconsistencies, and future research should control for this. 
However, given that an improvement in decentering abilities (measured by the EQ) was found in 
addition to one of the emotional acceptance facets in the current study following ayahuasca use, 
further supports the notion that ayahuasca has the capacity to affect both attentional and emotional 




This is because decentering to some extent involves a non-evaluative (or non-judgmental) perception 
of present moment experience in order for a person to take a more detached stance from their 
experiences as they arise into awareness. Given that changes in mindfulness following ayahuasca use 
remained significant regardless of previous ayahuasca use in the current study, supports previous 
findings (e.g. Soler et al 2017) that ayahuasca can affect mindfulness abilities in experienced 
ayahuasca users as well as less experienced users; even psychedelic naïve users. Clinically this is 
particularly beneficial since it suggests even those who are naïve to ayahuasca may benefit from 
mindfulness gains following a single ayahuasca session. The current findings suggest mindfulness 
warrants further investigation as a possible psychological mechanism of ayahuasca associated with its 
therapeutic potential. Further research exploring how mindfulness is affected beyond the 24 hour 
‘afterglow’ period, would offer further insight into the therapeutic window of such mindfulness gains 
and whether there are any longer term gains made by experienced users in mindfulness or cognitive 
flexibility. 
 
The current study reports significant differences in cognitive flexibility 24 hours after ayahuasca 
ingestion relative to baseline, regardless of prior ayahuasca use. Evidence for changes in flexible 
thinking come from both a subjective self-report questionnaire measure (e.g. significantly higher 
mean scores on the CFS 24 hours after ayahuasca use) and a more objective measure of cognitive 
flexibility; the WPCST. Mean number of correct answers on the WPSCT was significantly increased 
after ayahuasca use, with reaction times maintained, suggesting accuracy was improved without a 
significant slowing of response time. The current study reports significant differences in cognitive 
flexibility 24 hours after ayahuasca ingestion relative to baseline, regardless of prior ayahuasca use. 
Evidence for changes in flexible thinking in this study come from both a subjective self-report 
questionnaire measure (e.g. significantly higher mean scores on the CFS 24 hours after ayahuasca 
use) and a more objective measure of cognitive flexibility; the WPCST. Mean number of correct 
answers on the WPSCT was significantly increased after ayahuasca use, with reaction times 
maintained, suggesting accuracy was improved without a significant slowing of response time.  This 
is contrary to the findings of Uthaug et al., (2018) who assessed cognitive flexibility the day after 
ayahuasca and 4 weeks later with the Picture Concept Task. They found no significant differences for 
more flexible divergent thinking at either time point compared to baseline, and convergent thinking 
was significantly increased only at the 4 week point. The difference in findings could be a result of 
the different tasks used which may tap into a number of different aspects of cognitive flexibility, or 
indeed could perhaps be measuring two distinct but overlapping constructs (eg. creativity (PCT) and 
cognitive flexibility (WPCST)). The improvements shown in cognitive flexibility in the current study 
are consistent with recent neurobiological research into ayahuasca, reporting changes to neural 
networks associated with cognitive flexibility, both acutely and in the afterglow period (and up to 2 
months after use) (Sampedro et al.,2017). Changes to neural network functioning in this period may 
14 
 
also alter neuropsychological functioning which could help to account for the changes in cognitive 
flexibility shown in this study. Whilst the Stroop findings failed to show an effect of ayahuasca on 
Stroop interference (arguably cognitive flexibility), there was some indication ayahuasca had an effect 
on general Stroop task performance, since errors in the incongruent condition were significantly 
reduced post-ayahuasca, indicating performance improvements specifically on interference trials of 
the Stroop and such improvements warrant further investigation. Such changes in cognitive flexibility 
could be therapeutically significant because a loosening of “cognitive grip” may be helpful for 
example in depressed patients who suffer from ruminative thinking and are ‘stuck’ in certain patterns 
of thoughts and behaviours. Supporting patients to consider alternative behavioural strategies and 
broaden perspectives is a key therapeutic goal of cognitive behavioural therapy (Kuypers et al., 2016). 
Given the current study reports changes in cognitive flexibility in both subjective and more objective 
task-based measures, therefore lends strong support to the assertion that cognitive flexibility is 
another potential psychological mechanism of action involved in the therapeutic effects of ayahuasca.  
 
Whilst this study shows both improved cognitive flexibility and mindfulness gains in the afterglow 
period, it is not without its limitations. Firstly, it needs acknowledging that the WCST and the Stroop 
are very prone to learning and practice effects. Whilst parallel versions of the tasks were used for 
different time periods (pre- and post) with different trial orders and sorting rules (in the case of the 
WCST) applied in an attempt to reduce these effects, learning and practice effects can not be ruled 
out.  Secondly, drug use data is self-report and not biologically verified. In addition, the dose of 
ayahuasca taken by participants was unknown to the researchers and not recorded.  The a priori 
hypothesis were to assess any changes within the ‘afterglow period, as such, we did not capture any 
data on the acute effects, and therefore are unable to assess any influence of such pre-post-acute 
effects on these changes. The absence of a control group also limits the generalisation of findings. 
Whilst the current study employed a good sample size of healthy users, they were a self-selected 
sample and largely experienced with ayahuasca, limiting the generalisability of the findings to 
psychedelic naive and clinical samples. However, relative to previous studies investigating 
mindfulness and neuropsychological functioning of ayahuasca users, the current sample was 
considerably less experienced overall in terms of previous ayahuasca use which is a strength. 
 
In conclusion, the present study provides further evidence of ayahuasca’s ability to enhance 
mindfulness and highlights it as a potential psychological mechanism of the psychotherapeutic effects 
ayahuasca. In addition, it’s the first to report that ayahuasca improves cognitive flexibility in the 
‘afterglow’ period and suggests this is another possible psychological mechanism worthy of further 
exploration. Given that prior ayahuasca exposure had no significant effect on gains made to 
mindfulness and cognitive flexibility in the afterglow period highlights the potential beneficial effects 
of this psychedelic to both naïve and experienced users. The ‘afterglow’ effect of ayahuasca is 
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significant therapeutically and understanding the psychological mechanisms which occur during this 
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